ArticleJournal of inflammation research2025
The Predictive Value of ADC Values, Degree of Edema and the Systemic Immune-Inflammation Index for Early Postoperative Recurrence in High-Grade Gliomas.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pre-Radiotherapy Synthetic MRI-Derived Quantitative Heterogeneity and Early Recurrence in Glioblastoma.Journal of magnetic resonance imaging : JMRI · 2026Observational
- Potential Diagnostic and Prognostic Value of Neutrophil Counts, Neutrophil-Lymphocyte Ratio, Pan-Immunoinflammatory Score, Systemic Immunoinflammatory Index, and Systemic Inflammatory Response Index in Brain Tumors.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to evaluate the predictive value of apparent diffusion coefficient (ADC) values, degree of edema and the systemic immune-inflammation index (SII) for early postoperative recurrence in high-grade gliomas (HGG). Methods: This retrospective study analyzed data from patients with HGG who underwent surgery at the Second People's Hospital of Hunan Province between May 2018 and June 2023. Patients were divided into early recurrence (within six months post-surgery) and non-early recurrence groups. Receiver operating characteristic (ROC) curves were used to develop predictive models for early recurrence of HGG based on ADC, degree of edema and SII. Results: A total of 68 patients with HGG were included, of whom 20 (29.5%) had early recurrence. Significant differences were observed between the early recurrence and non-early recurrence groups in age, tumor size, degree of edema, and Pathologic grading (all P < 0.05). The area under the ROC curve (AUC) for tumor ADC was 0.623 (95% CI: 0.461-0.786) with a sensitivity of 0.500 and a specificity of 0.854; for degree of edema, it was 0.652 (95% CI: 0.517-0.787) with a sensitivity of 0.900 and a specificity of 0.458; and for SII, it was 0.781 (95% CI: 0.663-0.900) with a sensitivity of 0.750 and a specificity of 0.729. The combined model yielded an AUC of 0.823 (95% CI: 0.715-0.931) with a sensitivity of 0.800 and a specificity of 0.708. Conclusion: The combined evaluation of tumor ADC values, SII, and the degree of edema offers predictive value for early recurrence in HGG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.